Oramed Pharmaceuticals ORMP
NASDAQ ORMP
$4.49 +0.01 (+0.22%)
At close: Oct 2, 2026 · 4:00 PM EDT

Oramed Pharmaceuticals (ORMP) Return on Capital Employed [ROCE] (2011 - 2026)

Updated

Oramed Pharmaceuticals' Return on Capital Employed [ROCE] was -4.71% in Q2 2026, up 4.35 percentage points from -9.06% a year earlier and up 1.25 percentage points from the prior quarter.

Analysis

Oramed Pharmaceuticals (ORMP) Return on Capital Employed [ROCE] (2011 - 2026) Analysis & Trends

For FY2025, Return on Capital Employed [ROCE] at Oramed Pharmaceuticals came in at -8.67%, down 1.66 percentage points from FY2024.

  • Return on Capital Employed [ROCE] shows a five-year change of -41.46 percentage points (FY2020 to FY2025).
  • In earlier years, Return on Capital Employed [ROCE] was -7.01% in FY2024 (+4.42 pp), -11.44% in FY2023 (+13.32 pp), -24.76% in FY2022 (-33.18 pp) and 8.42% in FY2021.
  • The Q2 2026 figure marks the highest quarterly Return on Capital Employed [ROCE] since Q3 2016.
  • Compared with a year earlier, Return on Capital Employed [ROCE] has increased for four straight quarters, with an average year-over-year change of +2.43 percentage points over the last eight quarters.
  • The best year-over-year quarter for Return on Capital Employed [ROCE] over five years was Q4 2023 (a gain of 18.31 percentage points); the worst was Q1 2023 (a drop of 12.09 percentage points).
  • Per Business Quant data, ORMP's Return on Capital Employed [ROCE] in the three quarters before Q2 2026 was -5.95% (Q1 2026), -7.30% (Q4 2025) and -7.03% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 17.83%
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 17.92%
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 6.28%
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn 19.32%
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn 9.54%
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 16.66%
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn -5.97%
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn 11.86%
10 Oramed Pharmaceuticals 185.09 Mn 185.09 Mn - -4.71%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -4.71%
Mar 31, 2026 -5.95%
Dec 31, 2025 -7.30%
Sep 30, 2025 -7.03%
Jun 30, 2025 -9.06%
Mar 31, 2025 -9.81%
Dec 31, 2024 -8.27%
Sep 30, 2024 -7.71%
Jun 30, 2024 -6.76%
Mar 31, 2024 -7.57%
Dec 31, 2023 -9.14%
Sep 30, 2023 -20.98%
Jun 30, 2023 -18.80%
Mar 31, 2023 -23.85%
Dec 31, 2022 -27.45%
Sep 30, 2022 -21.22%
Jun 30, 2022 -17.06%
Mar 31, 2022 -11.76%
Nov 30, 2019 -43.95%
Aug 31, 2019 -47.60%
API Access

Oramed Pharmaceuticals Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=ORMP&period=max&api_key=YOUR_API_KEY